Latest Breaking News On - Immunoassay bioanalysis - Page 1 : comparemela.com

Agilex Biolabs and B2S Life Sciences on Immunoassay Bioanalysis for Clinical Trials ADELAIDE, AUS, Apr 29, 2021 - (ACN Newswire) - Agilex Biolabs, Australia s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, and B2S Life Sciences, a biotherapeutic enablement company advancing improved analytical methods and outcomes for developers of biotherapeutic drugs and diagnostics, shared key ways to navigate the immunogenicity and biomarker requirements for clinical trials via webinar. Watch the webinar here (no registration required): https://bit.ly/3sZp8IA / https://youtu.be/x0H9a8oCb98 Hot Topics in Immunoassay Bioanalysis - Key points in navigating the immunogenicity and biomarker requirements for clinical trials was presented by Endpoints Webinars on April 6. Hosted by Endpoints Editor Arsalan Arif, the webinar featured Dr Kurt J. Sales, Agilex Biolabs Director of Immunoassay, Ronald R. Bowsher PhD, Partner and Chief Scientific Offic

United statesSouth australiaKate newtonAmy rosenLuminex magpixKostenloser wertpapierhandelRonaldr bowsherAgilex biolabArsalan arifAgilex biolabsUs life sciencesLife sciencesImmunoassay bioanalysisEndpoints webinarsEndpoints editor arsalan arifAgilex biolab director